1.
Kittai AS, Best S, Thurlow B, Lam V, Hashiguchi T, Goodyear S, Persky DO, Okada C, Park B, Spurgeon SE, Danilov AV. Entospletinib and obinutuzumab in patients with relapsed/refractory chronic lymphocytic leukemia and B-cell malignancies. haematol [Internet]. 2021Jan.28 [cited 2021Jul.29];106(7):2022-5. Available from: https://haematologica.org/article/view/haematol.2020.270298